We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Histone Deacetylase May Be a Novel Therapeutic Strategy for Lung Cancer

News   Mar 27, 2020 | Original story from the Moffitt Cancer Center

 
Histone Deacetylase May Be a Novel Therapeutic Strategy for Lung Cancer

Credit: iStock

 
 
Advertisement
 

RELATED ARTICLES

A Quicker Way To Make Antibody–Drug Conjugates

News

A team has engineered a new, faster way to make antibody–drug conjugates that precisely target malignant cells, while leaving healthy tissue undamaged, that could lead the way to better treatments for numerous types of cancer.

READ MORE

Large Pathogenic Role for a Small Bacterial Protein

News

In meningococci, the RNA-binding protein ProQ plays a major role. Together with RNA molecules, it regulates processes that are important for pathogenic properties of the bacteria.

READ MORE

Paper-based Tech Advances Earlier Cancer Detection

News

A team has developed a technology that is more than 30 times more sensitive than current lab-based tests in finding early stage cancer biomarkers in blood.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE